Back

Prognostic impact of obstructive sleep apnea on major cardiovascular outcomes in patients with atrial fibrillation

30 August 2026 (17:12 - 17:24)
Organised by: Logo
Congress Presentation Part of: Sleep apnoea and cardiovascular disease Sleep Apnoea ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Miss Shalini Shaila Maria Lobo

National University of Singapore, Singapore (Singapore)

4 More presentations in this session

Presentation thumbnail
Cardiovascular disease modifies blood pressure response to mandibular advancement therapy versus CPAP in obstructive sleep apnea: a prespecified subgroup analysis of the CRESCENT trial
Doctor Y. Ou (Boston, US)
Abstract Slides
Presentation thumbnail
Synergistic prognostic value of event-aligned heart rate surge and hypoxic burden for cardiovascular mortality in sleep apnoea
Doctor Z. Huang (Beijing, CN)
Abstract Slides
Presentation thumbnail
Sleep parameters derived from smartwatch sphygmomanometer are associated with systolic blood pressure and time in therapeutic range: a large-scale real-world longitudinal study
Doctor Y. Chen (Beijing, CN)
Abstract Slides
Presentation thumbnail
Multidimensional physiological burden of nocturnal respiratory events improves the prediction of cardiovascular mortality in obstructive sleep apnoea
Doctor Z. Huang (Beijing, CN)
Abstract Slides

Access the full session

Session thumbnail
Sleep apnoea and cardiovascular disease
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 17:12 CET
You may be interested in
thumbnail
Congress Presentation
Impact of obstructive sleep apnoea on long-term atrial fibrillation-free survival after catheter ablation
28 August 2022
thumbnail
Congress Presentation
Major adverse cardiac events in acute coronary syndrome patients with atrial fibrillation
1 July 2021
thumbnail
Congress Presentation
The prognostic value of hypoxemic burden measured by overnight oximetry in heart failure patients with preserved ejection fraction
21 May 2023
thumbnail
Congress Presentation
Clinical and prognosis assessment of Atrial Fibrillation patients with significant valvular disease. Validation of the EHRA valve classification (Evaluated Heartvalves. Rheumatic or Artificial)
29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources